WHC is still in active development. Read this to understand our approach.
depiction of OROGSEYTTFOCAN-UHFFFAOYSA-N.svg
tripsit

codeine

Check on tripsit

psychonaut

Codeine

Check on psychonaut

isomerdesign

Codeine

Check on isomerdesign

isomerdesign

Isocodeine

Check on isomerdesign

pubchem

Codeine

Check on pubchem

druglab

Codéine

Check on druglab

drugmap

Codeine

Check on drugmap

wiki

Codeine

Check on wiki

wiki

Isocodeine

Check on wiki

Data

InChI: InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3

Synonyms: DTXCID40341,Codeine Alkaloid, Norcodeine, N-methyl,7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol,Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-,Codeinum monohydricum,(1S,13R,14S,17R)-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0(1,13).0(5,17).0(7,18)]octadeca-7(18),8,10,15-tetraen-14-ol,(5alpha,6alpha)-17-methyl-3-(methyloxy)-7,8-didehydro-4,5-epoxymorphinan-6-ol, Norcodine, N-methyl,Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)- (9CI), O(3)-methylmorphine,(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol, Morphine-3-methyl ester,Codeine Anhydrate,UNII-UX6OWY2V7J,Codein,Codicept,10-methoxy-4-methyl-(13R,14S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-ol(Dihydrocodeine),(Codeine),AKOS015955539, UNII-UX6OWY2V7J,Norcodine, N-methyl,Tox21_200082,CAS-76-57-3,HSDB 3043,C06174, Codeine Anhydrate, O3-Methylmorphine,3-methoxy-17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-6alpha-ol,10-methoxy-4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraen-14-ol(codeine phosphate),MORPHINE HYDROCHLORIDE IMPURITY A [ EP IMPURITY],Codeine [INN:BAN], CCRIS 7555,DSSTox_GSID_20341,Morphinan-6alpha-ol, 7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methyl- (8CI),MYTUSSIN,O(3)-methylmorphine,(1S,5R,13R,14S,17R)-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0?,??.0?,??.0?,??]octadeca-7,9,11(18),15-tetraen-14-ol, CODEINE BASE,Morphine monomethyl ether, codeinum,CHEBI:16714,Codeine 0.1 mg/ml in Methanol, 76-57-3,3-Methylmorphine,Norcodeine, N-methyl, l-Codeine,ZINC3806721,BDBM50105098, CHEBI:16714,10-methoxy-4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraen-14-ol(codeine (H3PO4)),codeine, Codeine polistirex,codeinum,Codeine (CRM), Methylmorphine, Codeine anhydrous,Methylmorphine, Morphine-3-methyl ether, UX6OWY2V7J,Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5-alpha,6-alpha)-,Codeine anhydrous,DIHYDROCODEINE HYDROGEN TARTRATE IMPURITY A [EP IMPURITY],(codeine)10-methoxy-4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraen-14-ol,10-methoxy-4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraen-14-ol phosphate(codeine),SCHEMBL3257, (-)-Codeine,(-)-Codeine,(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol,Codeine solution, analytical standard, for drug analysis, 1.0 mg/mL in methanol,Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5.alpha.,6.alpha.)-,DSSTox_RID_75524,Q174723, codeina,AC-11114,CODEINE [WHO-DD],KODELAK FITO,DTXSID2020341,Codeine polistirex [USAN],Codeine 1.0 mg/ml in Methanol,CCRIS 7555,l-Codeine,CODEINE BASE,76-57-3,codeina,SS85U8K5ZN, Morphine 3-methyl ether,UX6OWY2V7J,MORPHINE SULFATE IMPURITY A [EP IMPURITY],IDS-NC-005(SECT.-2),HYDROCODONE HYDROGEN TARTRATE 2.5-HYDRATE IMPURITY C [EP IMPURITY],CHEMBL485,DSSTox_CID_341,Coducept,CHEMBL369475,Epitope ID:120369,10-methoxy-4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraen-14-ol[codeine], Codein,Codeine,Morphinan-6-alpha-ol, 7,8-didehydro-4,5-alpha-epoxy-3-methoxy-17-methyl-, EINECS 200-969-1,Morphine-3-methyl ether, Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-,Isocodeine,CODEINE [HSDB],Codeine, European Pharmacopoeia (EP) Reference Standard,Morphinan-6alpha-ol, 7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methyl-,EINECS 200-969-1,Codeine solution, 1 mg/mL in methanol, ampule of 1 mL, certified reference material, Morphine monomethyl ether,Morphine 3-methyl ether,10-methoxy-4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraen-14-ol,Codeine USP,(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol,Codeine polistirex, HSDB 3043, Coducept,GTPL1673,7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol,(1S,5R,13R,14S,17R)-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7,9,11(18),15-tetraen-14-ol,O3-Methylmorphine,(1S,5R,13R,14S,17R)-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10,15-tetraen-14-ol,NCGC00257636-01,BDBM50019351,CODEINE [MI],NCGC00248518-01,Morphine-3-methyl ester, Codicept,7,8-DIDEHYDRO-4,5.ALPHA.-EPOXY-3-METHOXY-17-METHYLMORPHINAN-6.ALPHA.-OL,10-methoxy-4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraen-14-ol(Codeine),DB00318

Estimated data

Solubility: -2.605 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 100.0% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.